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Background
Since 1992, the Ministry of Public Health has integrated
newborns HBV vaccination into the national expanded
program on immunization. However, some children
acquire HBV infection despite immunization.
Objective
To characterize HBV vaccine escape mutants in infants
born to HBV/HIV-1 co-infected mothers.
Methods
Of 1433 HIV-infected women participating in the perina-
tal HIV prevention trial (PHPT-1), 107 were HBsAg posi-
tive. Five transmitted HBV to their children despite HBV
vaccination in their children were documented. Blood
samples collected from mothers during pregnancy and
children at 4 and 6 months of age were analyzed by direct
PCR sequencing of the S gene ("a" determinant region and
flanking regions). HBV variants were sequenced after
cloning of PCR products into pGEM-T® easy vector (20–25
clones by samples). Sequencing was performed using the
BigDye Terminator V.3.1 sequencing kit, Applied Biosys-
tem. Sequence alignments were performed using Bioedit
software. HBV serotype was inferred from results at
codons 122, 127, 160, 177 and 178 of the S gene.
Results
Complete samples series were available for 3 mother-
child pairs, all infected by HBV genotype C. Infant virus
direct sequencing showed no known vaccine escape muta-
tion. However, direct sequencing identified the sK122R
mutation in 2 infants but not in their mother. The pre-
dicted dominant HBV serotype in the 2 mothers was
adrq+, while it was ayr in the 2 children at 4 months of age.
Although sK122R was not detected by direct sequencing,
further analysis of maternal clones showed that the 2
mothers harbored this minor variant at very low fre-
quency (1 of 65 clones and 2 of 67 clones, respectively).
Analysis of children HBV clones showed an increase of ayr
variants from 4 months to 6 months.
Conclusion
Although the impact of the sK122R mutation on HBV vac-
cine escape is unknown, this study suggests that HBV
minor maternal variants defining serotype can be trans-
mitted to children who received HBV vaccine. This obser-
vation justifies the systematic virological evaluation of
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